Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma

Open access
Yao, Xiaosai, Tan, Jing, Lim, Kevin Junliang, Koh, Joanna, Ooi, Wen Fong, Li, Zhimei, Huang, Dachuan, Xing, Manjie, Chan, Yang Sun, Qu, James Zhengzhong, Tay, Su Ting, Wijaya, Giovani, Lam, Yue Ning, Hong, Jing Han, Lee-Lim, Ai Ping, Guan, Peiyong, Ng, Michelle Shu Wen, He, Cassandra Zhengxuan, Lin, Joyce Suling, Nandi, Tannistha, Qamra, Aditi, Xu, Chang, Myint, Swe Swe, Davies, James O. J., Goh, Jian Yuan, Loh, Gary, Tan, Bryan C., Rozen, Steven G., Yu, Qiang, Tan, Iain Bee Huat, Cheng, Christopher Wai Sam, Li, Shang, Chang, Kenneth Tou En, Tan, Puay Hoon, Silver, David Lawrence, Lezhava, Alexander, Steger, Gertrud, Hughes, Jim R., Teh, Bin Tean, Tan, Patrick·2017·Cancer Discovery

Abstract

Protein-coding mutations in clear cell renal cell carcinoma (ccRCC) have been extensively characterized, frequently involving inactivation of the von Hippel–Lindau (VHL) tumor suppressor. Roles for noncoding cis-regulatory aberrations in ccRCC tumorigenesis, however, remain unclear. Analyzing 10 primary tumor/normal pairs and 9 cell lines across 79 chromatin profiles, we observed pervasive enhancer malfunction in ccRCC, with cognate enhancer-target genes associated with tissue-specific aspects of malignancy. Superenhancer profiling identified ZNF395 as a ccRCC-specific and VHL-regulated master regulator whose depletion causes near-complete tumor elimination in vitro and in vivo. VHL loss predominantly drives enhancer/superenhancer deregulation more so than promoters, with acquisition of active enhancer marks (H3K27ac, H3K4me1) near ccRCC hallmark genes. Mechanistically, VHL loss stabilizes HIF2α–HIF1β heterodimer binding at enhancers, subsequently recruiting histone acetyltransferase p300 without overtly affecting preexisting promoter–enhancer interactions. Subtype-specific driver mutations such as VHL may thus propagate unique pathogenic dependencies in ccRCC by modulating epigenomic landscapes and cancer gene expression. Significance: Comprehensive epigenomic profiling of ccRCC establishes a compendium of somatically altered cis-regulatory elements, uncovering new potential targets including ZNF395, a ccRCC master regulator. Loss of VHL, a ccRCC signature event, causes pervasive enhancer malfunction, with binding of enhancer-centric HIF2α and recruitment of histone acetyltransferase p300 at preexisting lineage-specific promoter–enhancer complexes. Cancer Discov; 7(11); 1284–305. ©2017 AACR. See related commentary by Ricketts and Linehan, p. 1221. This article is highlighted in the In This Issue feature, p. 1201

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-17-0375

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 166

Metadata

Authors
Yao, X., Tan, J., Lim, K. J., Koh, J., Ooi, W. F., Li, Z., Huang, D., Xing, M., Chan, Y. S., Qu, J. Z., Tay, S. T., Wijaya, G., Lam, Y. N., Hong, J. H., Lee-Lim, A. P., Guan, P., Ng, M. S. W., He, C. Z., Lin, J. S., Nandi, T., Qamra, A., Xu, C., Myint, S. S., Davies, J. O. J., Goh, J. Y., Loh, G., Tan, B. C., Rozen, S. G., Yu, Q., Tan, I. B. H., Cheng, C. W. S., Li, S., Chang, K. T. E., Tan, P. H., Silver, D. L., Lezhava, A., Steger, G., Hughes, J. R., Teh, B. T., & Tan, P.
Venue
Cancer Discovery
Published
2017-11-01
Volume
7
Issue
11
Pages
1284-1305
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2754569966
Cited by
166
References
29
FWCI
4.95
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma. https://app.cochat.ai/papers/10.1158/2159-8290.cd-17-0375
The paper
Yao, X., Tan, J., Lim, K. J., Koh, J., Ooi, W. F., Li, Z., Huang, D., Xing, M., Chan, Y. S., Qu, J. Z., Tay, S. T., Wijaya, G., Lam, Y. N., Hong, J. H., Lee-Lim, A. P., Guan, P., Ng, M. S. W., He, C. Z., Lin, J. S., . . . Tan, P. (2017). VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-17-0375

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.